Galectin-3 as a candidate upstream biomarker for quantifying risks of myocardial ageing.
Bryan M H KengFei GaoSee Hooi EweRu San TanLouis L Y TeoBei Qi XieWoon-Puay KohAngela S KohPublished in: ESC heart failure (2019)
Among asymptomatic community-dwelling elderly adults, the highest quartile of Gal-3 was associated with two-fold increased odds of myocardial dysfunction compared with the lowest quartile of Gal-3. Gal-3 may have a role as an 'upstream' biomarker in estimating odds of myocardial ageing prior to clinical disease.